Literature DB >> 14681908

Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database.

Maria Karayiorgou1, Marie Torrington, Gonçalo R Abecasis, Herman Pretorius, Brian Robertson, Sean Kaliski, Stephen Lay, Christina Sobin, Natalie Möller, S Laura Lundy, Maude L Blundell, Joseph A Gogos, J Louw Roos.   

Abstract

Founder populations hold tremendous promise for mapping genes for complex traits, as they offer less genetic and environmental heterogeneity and greater potential for genealogical research. Not all founder populations are equally valuable, however. The Afrikaner population meets several criteria that make it an ideal population for mapping complex traits, including founding by a small number of initial founders that likely allowed for a relatively restricted set of mutations and a large current population size that allows identification of a sufficient number of cases. Here, we examine the potential to conduct genealogical research in this population and present initial results indicating that accurate genealogical tracing for up to 17 generations is feasible. We also examine the clinical similarities of schizophrenia cases diagnosed in South Africa and those diagnosed in other, heterogeneous populations, specifically the US. We find that, with regard to basic sample descriptors and cardinal symptoms of disease, the two populations are equivalent. It is, therefore, likely that results from our genetic study of schizophrenia will be applicable to other populations. Based on the results presented here, the history and current size of the population, as well as our previous analysis addressing the extent of background linkage disequilibrium (LD) in the Afrikaners, we conclude that the Afrikaner population is likely an appropriate founder population to map genes for schizophrenia using both linkage and LD approaches. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14681908     DOI: 10.1002/ajmg.b.20090

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  Identifying nineteenth century genealogical links from genotypes.

Authors:  Jim Stankovich; Melanie Bahlo; Justin P Rubio; Christopher R Wilkinson; Russell Thomson; Annette Banks; Maree Ring; Simon J Foote; Terence P Speed
Journal:  Hum Genet       Date:  2005-05-10       Impact factor: 4.132

2.  Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1.

Authors:  Gonçalo R Abecasis; Rachel A Burt; Diana Hall; Sylvia Bochum; Kimberly F Doheny; S Laura Lundy; Marie Torrington; J Louw Roos; Joseph A Gogos; Maria Karayiorgou
Journal:  Am J Hum Genet       Date:  2004-01-28       Impact factor: 11.025

3.  Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia.

Authors:  Laura Rodriguez-Murillo; Bin Xu; J Louw Roos; Gonçalo R Abecasis; Joseph A Gogos; Maria Karayiorgou
Journal:  Neuropsychopharmacology       Date:  2013-10-21       Impact factor: 7.853

4.  Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans.

Authors:  Bin Xu; Abigail Woodroffe; Laura Rodriguez-Murillo; J Louw Roos; Elizabeth J van Rensburg; Gonçalo R Abecasis; Joseph A Gogos; Maria Karayiorgou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-11       Impact factor: 11.205

5.  The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients.

Authors:  Katja Ribbe; Heidi Friedrichs; Martin Begemann; Sabrina Grube; Sergi Papiol; Anne Kästner; Martin F Gerchen; Verena Ackermann; Asieh Tarami; Annika Treitz; Marlene Flögel; Lothar Adler; Josef B Aldenhoff; Marianne Becker-Emner; Thomas Becker; Adelheid Czernik; Matthias Dose; Here Folkerts; Roland Freese; Rolf Günther; Sabine Herpertz; Dirk Hesse; Gunther Kruse; Heinrich Kunze; Michael Franz; Frank Löhrer; Wolfgang Maier; Andreas Mielke; Rüdiger Müller-Isberner; Cornelia Oestereich; Frank-Gerald Pajonk; Thomas Pollmächer; Udo Schneider; Hans-Joachim Schwarz; Birgit Kröner-Herwig; Ursula Havemann-Reinecke; Jens Frahm; Walter Stühmer; Peter Falkai; Nils Brose; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  BMC Psychiatry       Date:  2010-11-10       Impact factor: 3.630

6.  Exome sequencing supports a de novo mutational paradigm for schizophrenia.

Authors:  Bin Xu; J Louw Roos; Phillip Dexheimer; Braden Boone; Brooks Plummer; Shawn Levy; Joseph A Gogos; Maria Karayiorgou
Journal:  Nat Genet       Date:  2011-08-07       Impact factor: 38.330

Review 7.  Early deviant behaviour as a dimension trait and endophenotype in schizophrenia.

Authors:  Johannes L Roos; Carla Kotzé
Journal:  S Afr J Psychiatr       Date:  2022-04-29       Impact factor: 1.242

8.  Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches.

Authors:  Ruby Hsu; Abigail Woodroffe; Wen-Sung Lai; Melloni N Cook; Jun Mukai; Jonathan P Dunning; Douglas J Swanson; J Louw Roos; Gonçalo R Abecasis; Maria Karayiorgou; Joseph A Gogos
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

9.  Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.

Authors:  T Karayannis; E Au; J C Patel; I Kruglikov; S Markx; R Delorme; D Héron; D Salomon; J Glessner; S Restituito; A Gordon; L Rodriguez-Murillo; N C Roy; J A Gogos; B Rudy; M E Rice; M Karayiorgou; H Hakonarson; B Keren; G Huguet; T Bourgeron; C Hoeffer; R W Tsien; E Peles; G Fishell
Journal:  Nature       Date:  2014-07-10       Impact factor: 69.504

10.  Family history identifies sporadic schizoaffective disorder as a subtype for genetic studies.

Authors:  Nicolaas J van der Merwe; Maria Karayiorgou; René Ehlers; Johannes L Roos
Journal:  S Afr J Psychiatr       Date:  2020-04-20       Impact factor: 1.550

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.